RESTYLANE^® LYFT LIDOCAINE

Galderma, through modern technology, has created a hyaluronic acid that is 99% similar to the natural one found in the body. This acid is stabilized and of non-animal origin.

The NASHA particle size in RESTYLANE® products is adapted to the tissue structure of the specific skin layer. The concentration of hyaluronic acid in all RESTYLANE® products is the same, but it varies in particle size and injection depth. This allows RESTYLANE® to offer a full range of products that can be matched to the type and depth of wrinkles, achieving a very good and natural effect.

The products have high lifting and firming capabilities with minimal injection volume. The effect after the procedure lasts for a period of 6-12 months, depending on the patient's skin condition. After this time, RESTYLANE® is naturally absorbed.

RESTYLANE® is the first hyaluronic acid product approved in the USA by the Food and Drug Administration (FDA) for aesthetic medicine.

RESTYLANE® Lyft (Perlane) lidocaine achieves a naturally looking result and, most importantly, does not affect facial muscle expression and movements. It is not a permanent product, avoiding a lasting effect.

RESTYLANE® Lyft (Perlane) reduces deeper wrinkles and folds, shapes the face contour, and provides a lifting effect by injecting into the deep layer of the dermis.

The product contains lidocaine, which makes the procedure painless and eliminates the need for prior anesthesia.

INDICATIONS

• filling of deeper wrinkles such as nasolabial folds,
• increasing lip volume,
• lip color enhancement,
• lifting lip corners,
• shaping the facial contour and cheeks,
• marionette lines,
• filling the tear trough,
• chin modeling,
• temple shaping.

COMPOSITION

Hyaluronic acid (HA) concentration: 20 mg/ml

Lidocaine: 0.3%

NASHA particle size: 10,000

PACKAGING

1 vial-syringe containing 1 ml of the product

2 27G needles

CONTRAINDICATIONS

• in areas or near areas with skin inflammations or infections (acne, rash),
• in combination with peelings, laser therapy, and dermabrasion,
• propensity to form hypertrophic scars,
• hypersensitivity to hyaluronic acid, mannitol, lidocaine hydrochloride, or topically applied anesthetics,
• patients with porphyria,
• reduced blood coagulation,
• allergy, including to chromium and nickel,
• taking blood-thinning medications (e.g., Aspirin, Polocard),
• pregnant women, breastfeeding women, and children,
• menstruation,
• taking antibiotics (up to 2 weeks after completing antibiotic therapy).

TREATMENT METHOD

The procedure should be performed by a specialist familiar with the method of administration.

The recommended injection depth depends on the type of wrinkle and the chosen technique.

Before the procedure, patients should be informed about possible side effects and risks.

After the injection, the doctor may gently massage the treated area to evenly distribute the product and achieve the desired effect.

After the procedure, slight swelling, redness, or minor bruises may appear, which disappear after a few hours to a few days.

STORAGE

Store at temperatures from 0 to 25°C. Protect from sunlight and frost. Do not freeze. Keep out of reach of children.

MANUFACTURER

Galderma

This product is for professional use only. By purchasing, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.

Before use, familiarize yourself with the content of the leaflet included in the package.